Z-0135-2023 Class III Terminated

Recalled by LumiraDx — Waltham, MA

FDA device recall Z-0135-2023 was initiated by LumiraDx on Sep 23, 2022 and is designated Class III. Reason for recall: Assigned vial lot numbers for the incorrect type of product. SARS-CoV-2 & Flu A/B lot numbers were incorrectly assigned to the positive and negative vial lot numbers for SARS-CoV-2 Ag LQCs within… The recall status is terminated (terminated Dec 13, 2024). Affected quantity: 83 kits.

Recall details

Product Type
Devices
Report Date
Nov 2, 2022
Initiation Date
Sep 23, 2022
Termination Date
Dec 13, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
83 kits

Product description

LumiraDx SARS-CoV-2 Antigen (Ag) Liquid Quality Control Kit Catalog #: L016080109002 (EUA) The LumiraDx SARS-CoV-2 Quality Controls are intended for liquid quality control testing performed on the LumiraDx Instrument when used with the LumiraDx SARS-CoV-2 Ag Test Strip. The Quality Controls provide users with assurance that the device is performing within specification

Reason for recall

Assigned vial lot numbers for the incorrect type of product. SARS-CoV-2 & Flu A/B lot numbers were incorrectly assigned to the positive and negative vial lot numbers for SARS-CoV-2 Ag LQCs within batch 2002204017, which should have been assigned SARS-CoV-2 Ag lot numbers resulting in an error message and preventing use of the LQC

Distribution pattern

US Nationwide distribution.

Code information

LQC Kit: 2002204017 Positive Control Vial: 1000 1710 0014 0141 Negative Control Vial: 1000 1720 0014 0142 Exp. Date: 01-Mar-2023

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0135-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0135-2023. Report a data issue: hello@regdatalab.com.